The American College of Cardiology is partnering with Chicago-based company Veradigm to assemble the largest-ever ambulatory chronic disease network in the U.S., comprising more than 250,000 clinicians and 100 million patients.
According to a statement from the ACC, the partnership with Veradigm hinges on the company’s tech, analytic capabilities and ability to leverage holistically integrated point-of-care data with reporting and provider workflows. Veradigm will focus on the ACC’s NCDR PINNACLE Registry and Diabetes Collaborative Registry.
“ACC and Veradigm are transforming how cardiovascular and diabetes care are delivered by providing clinicians access to the right clinical information at the right time to improve the outcomes of their patients,” ACC President Richard J. Kovacs, MD, said in the statement. “As information technology transforms how we practice medicine, it is essential that we partner with the most accomplished innovators to ensure our field has full access to the fruit of technology’s progress.
“Our partnership with Veradigm will ensure we continue to meet our commitments to registry participants while preparing to deliver a whole new generation of clinical tools and research opportunities.”
Apart from integrating Veradigm’s technology and analytics with two major ACC registries, the company will reportedly leverage its large specialist and primary care network on Allscripts and Practice Fusion electronic medical records “to bring ACC’s clinical guidelines, decision pathways and wealth of provider and patient engagement tools to the point of care.” Patients within the existing registries can also expect more opportunities to participate in research studies and increased access to evidence-based medicine and tools.